NEO-SYNALAR

Neomycin sulfate and fluocinonide acetate · Eurofarma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NEO-SYNALAR, covering 2015-02-25 to 2015-02-25. Get the full timeline:

Most recent: FDA Approved: NEO-SYNALAR — Supplemental Application (Eurofarma, Inc.)